Newsfeeds - Spark Newswire

2 minute read

Earnings

Looking Into Syneos Health’s Return On Capital Employed

Today, 7:08 AM

According to Benzinga Pro, during Q2, Syneos Health (NASDAQ:SYNH) earned $83.68 million, a 37.15% increase from the preceding quarter. Syneos Health also posted a total of $1.28 billion in sales, a 6.09% increase since Q1.

SYNH

2 minute read

Novan Engages Syneos Health As Commercial Solutions Provider For SB206

By Benzinga Newsdesk

Today, 7:08 AM

Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN), today announced its selection of Syneos Health (NASDAQ:SYNH), a fully integrated biopharmaceutical solutions organization, as its commercial

NOVN

5 minute read

The Daily Biotech Pulse: MacroGenics’ Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA’s FDA Nod

By Shanthi Rexaline

Today, 7:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7)

ADIL

5 minute read

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical

By Shanthi Rexaline

Today, 7:08 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26)

ABSI

13 minute read

Stocks That Hit 52-Week Highs On Friday

By Benzinga Insights

Today, 7:08 AM

Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.

1 minute read

Credit Suisse Maintains Outperform on Syneos Health, Raises Price Target to $100

By Benzinga Newsdesk

Today, 7:08 AM

Credit Suisse analyst Katie Tryhane maintains Syneos Health (NASDAQ:SYNH) with a Outperform and raises the price target from $96 to $100.

SYNH

1 minute read

Syneos Health: Q2 Earnings Insights

By Benzinga Insights

Today, 7:08 AM

Shares of Syneos Health (NASDAQ:SYNH) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were up 67.24% year over year to $0.97, which beat the estimate of $0.96.

SYNH

1 minute read

Syneos Health Q2 Adj. EPS $0.97 Beats $0.96 Estimate, Sales $1.28B Beat $1.27B Estimate

By Bill Haddad

Today, 7:08 AM

Syneos Health (NASDAQ:SYNH) reported quarterly earnings of $0.97 per share which beat the analyst consensus estimate of $0.96 by 1.04 percent. This is a 67.24 percent increase over earnings of $0.58 per share from the

SYNH

14 minute read

Earnings Scheduled For August 9, 2021

By Benzinga Insights

Today, 7:08 AM

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million.

ACM

7 minute read

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight

By Shanthi Rexaline

Today, 7:08 AM

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.

ABCL